INS and metabolic dysfunction-associated steatohepatitis: Systematic reviews, histological and meta-analyses studies have revealed that TZDs can lower serum transaminases and improve insulin sensitivity, liver steatosis, lobular inflammation, and ballooning in NASH patients [90].